Indirubin, the active constituent of a Chinese... [Nat Cell Biol. 1999] - PubMed

Save items

loading

Related citations in PubMed

Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? [J Biol Chem. 2001]
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernat J, Wu YZ, Mandelkow EM, et al. J Biol Chem. 2001 Jan 5; 276(1):251-60.
Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. [Oncogene. 2001]
Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
Damiens E, Baratte B, Marie D, Eisenbrand G, Meijer L. Oncogene. 2001 Jun 28; 20(29):3786-97.
Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. [J Med Chem. 2003]
Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects.
Mettey Y, Gompel M, Thomas V, Garnier M, Leost M, Ceballos-Picot I, Noble M, Endicott J, Vierfond JM, Meijer L. J Med Chem. 2003 Jan 16; 46(2):222-36.
Review Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. [J Cancer Res Clin Oncol. 2004]
Review Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine.
Eisenbrand G, Hippe F, Jakobs S, Muehlbeyer S. J Cancer Res Clin Oncol. 2004 Nov; 130(11):627-35. Epub 2004 Aug 31.
Review Chemical and biological profile of dual Cdk1 and Cdk2 inhibitors. [Curr Med Chem Anticancer Agent...]
Review Chemical and biological profile of dual Cdk1 and Cdk2 inhibitors.
Ruetz S, Fabbro D, Zimmermann J, Meyer T, Gray N. Curr Med Chem Anticancer Agents. 2003 Jan; 3(1):1-14.

See reviews... See all...

Cited by 28 PubMed Central articles

Investigation of the biosynthetic potential of endophytes in traditional chinese anticancer herbs. [PLoS One. 2012]
Investigation of the biosynthetic potential of endophytes in traditional chinese anticancer herbs.
Miller KI, Qing C, Sze DM, Neilan BA. PLoS One. 2012; 7(5):e35953. Epub 2012 May 22.
Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms. [PLoS One. 2012]
Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms.
Su Y, Cheng X, Tan Y, Hu Y, Zhou Y, Liu J, Xu Y, Xie Y, Wang C, Gao Y, et al. PLoS One. 2012; 7(3):e32782. Epub 2012 Mar 5.
Marine compounds selectively induce apoptosis in female reproductive cancer cells but not in primary-derived human reproductive granulosa cells. [Mar Drugs. 2012]
Marine compounds selectively induce apoptosis in female reproductive cancer cells but not in primary-derived human reproductive granulosa cells.
Edwards V, Benkendorff K, Young F. Mar Drugs. 2012 Jan; 10(1):64-83. Epub 2012 Jan 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits ...
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
Nat Cell Biol. 1999 May ;1(1):60-7.

PubMed
Astrocytes interact intimately with degenerating motor neurons in mouse amyotrop...
Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS).
Glia. 1999 Dec ;28(3):215-24.

PubMed
Double-lined frontoparietal scleroderma en coup de sabre.
Double-lined frontoparietal scleroderma en coup de sabre.
Dermatology. 1999 ;199(2):185-6.

PubMed
Cellular origin of human B-cell lymphomas.
Cellular origin of human B-cell lymphomas.
N Engl J Med. 1999 Nov 11 ;341(20):1520-9.

PubMed
Consistent viral evolutionary changes associated with the progression of human i...
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection.
J Virol. 1999 Dec ;73(12):10489-502.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 28 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information